Yuvaraj et al. genetically modified Escherichia coli for delivery of bone morphogenetic protein 2 that induces effective apoptosis in an in vitro model of CRC [82], which suggests that the strategy might be feasible for the treatment of CRC patients. The gene discussed is BMP2; the disease is colorectal carcinoma.